Added to YB: 2026-08-25
Pitch date: 2026-08-20
PCRX.V [neutral]
PharmaCorp Rx Inc.
-1.01%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs.
Market Cap
CAD 87.0M
Pitch Price
CAD 0.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.1K
P/E
-72.05
EV/Sales
2.48
Sector
Consumer Staples Distribution and Retail
Category
growth
Pharmacorp Rx ($PCRX.V) FINS Review
PCRX.V (earnings): Q2 rev $7.72M (+76% YoY), GM 40.3%, net income $121k vs -$385k loss. Aggressive Canadian pharmacy consolidator, now 16 locations (from 4 yr ago), 1100+ ROFR access. ~$100M mkt cap. Expect $40M+ rev this year, $100M by 2027. Compares to early Well Health. Risk: heavy dilution (48% YoY), $30M acquisition spend. 3.25-star rating maintained; picked at $0.425, +18%.
Read full article (4 min)